Center for Molecular Medicine Cologne

Sebastian Brähler - CAP 17

B- and T-cell lymphocyte attenuator (BTLA) as a central regulator of immunity in glomerulonephritis

Introduction

In progress - further information will follow soon.

  • Volker LA, Kaufeld J, Miesbach W, Brahler S, Reinhardt M, Kuhne L, Muhlfeld A, Schreiber A, Gaedeke J, Tolle M, Jabs WJ, Ozcan F, Markau S, Girndt M, Bauer F, Westhoff TH, Felten H, Hausberg M, Brand M, Gerth J, Bieringer M, Bommer M, Zschiedrich S, Schneider J, Elitok S, Gawlik A, Gackler A, Kribben A, Schwenger V, Schoenermarck U, Roeder M, Radermacher J, Bramstedt J, Morgner A, Herbst R, Harth A, Potthoff SA, von Auer C, Wendt R, Christ H, Brinkkoetter PT, and Menne J (2020b). ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP. Blood advances 4, 3093-101.
Dr. med. Sebastian Brähler CMMC Cologne
Dr. med. Sebastian Brähler

Clinic II of Internal Medicine

Principal Investigator CAP 17

Co-Principal Investigator - B 01

RG location - CMMC Building

+49 221 478 96978

Clinic II of Internal Medicine

Robert-Koch-Str. 21

50931 Cologne

https://www.kidneyresearchcenter.org/1/Home.htm

CMMC Profile Page

Curriculum Vitae (CV)

Publications on PubMed

Publications - Sebastian Brähler

Link to PubMed